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Amyloidosis is a form of plasma cell dyscrasia of unknown etiology, pathologically characterized by the extracel-
lular deposit of fibrils derived from the light chain of monoclonal immunoglobulin. The involvement of the airways 
is more common in primary amyloidosis and is classified into: tracheobronchial amyloidosis, nodular parenchymal, 
diffuse parenchymal. The tracheobronchial form is usually the most frequent and is characterized by the presence 
of multiple submucosal plaques or, more rarely, by pseudotumoral endobronchial masses. Symptoms in the initial 
phase may be silent, subsequently manifesting themselves with cough, dyspnea, hemoptysis. 
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Amyloid must be understood as any substance 
that presents a green birefringence under polar-
ized light, after Congo red staining, a fibrillar 
structure in electron microscopy. The deposit 
and infiltration of this substance constitutes Am-
yloidosis. Although at first it was believed that 
amyloid was a single substance, it is currently 
known that the proteins that constitute it are dif-
ferent, all similar to each other from a morpho-
logical point of view, but different from a bio-
chemical point of view (Piacenza 1992). Various 
proteins of this type have been identified in var-
ious combinations (immunoglobulins). The 
most important are amyloid L (AL) and amyloid 
A (AA). L amyloidosis derives from light chain 
immunoglobulins and is therefore usually asso-
ciated with an abnormal functioning of plasma 
cells (Prakash 1995), both localized in the lungs 
and as part of a systemic pathology such as mul-
tiple myeloma or macroglobulinemia. Amyloido-
sis A derives from an acute serum phase reagent 
(AAS) synthesized in the liver. The latter can 
form in various conditions, connective tissue 
diseases (in particular rheumatoid arthritis), 
chronic infections (in particular tuberculosis), 
bronchiectasis and some neoplasms (such as 
Hodgkin's lymphoma). Due to the great variety 
of clinical and pathological manifestations, amy-
loidosis has been classified above all in relation 
to its biochemical origin. The traditional classifi-
cation provides for four main forms of disease: 
Primary amyloidosis, in which no associated pa-
thology is recognized or there is a concomitant 
disorder of plasma cells (most often multiple 
myeloma); secondary amyloidosis, in which 
there is an underlying or identifiable chronic in-
flammatory disease, such as tuberculosis, bron-
chiectasis, rheumatic disease; hereditary amyloi-
dosis, a relatively rare form that can be localized 
in a specific tissue such as a nerve; Senile amy-
loidosis which affects many organs and tissues 
and is usually found in people over seventy 
(Fraser et al. 2006). The involvement of the res-
piratory tract can be isolated or integrated in the 
framework of a systemic amyloidosis that in-
volves all organs. The localized form is the most 
frequent. Respiratory amyloidosis can take three 
main and characteristic forms: tracheobronchial, 
nodular parenchymal (the nodules can be solitary 
located at the periphery of the lung or more of-
ten multiple), diffuse parenchymal (almost exclu-
sively affects the interstitium and is characterized 
by an infiltration of the alveolar wall by the am-
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yloid substance, especially around the capillar-
ies). The tracheobronchial form is probably the 
most frequent. It manifests itself with the pres-
ence of multiple submucosal plaques in the lu-
men of the trachea and bronchi or more rarely 
with a pseudotumoral endobronchial mass of a 
friable consistency that is easy to bleed, with an 
irregular surface, generally of a pinkish-yellowish 
color (Piacenza 1992). Radiologically, the lesions 
of the respiratory tract are visible at the level of 
the trachea, the main bronchi and the lobar and 
segmental bronchi. They can be observed on 
standard radiological examination and better still 
on CT. They are characterized by a focal or dif-
fuse thickening of the airways or they may pre-
sent the appearance of multiple nodules that de-
velop at the level of the tracheal wall, of the 
main, lobar, or segmental bronchi projecting 
into the lumen and can cause mild, moderate, or 
considerable entity. A rare and particular anom-
aly, called osteoplastic tracheopathy (character-
ized by diffuse or nodular ossification of the tra-
cheobronchial mucosa) can be similar to trache-
obronchial amyloidosis. As evidenced by some 
observations of amyloid deposits with histologi-
cal studies of these tracheae, it can be said that 
osteoplastic tracheopathy is a late stage in the 
evolution of tracheobronchial amyloidosis 
(Grenier 1993). 
 
2. Clinical Case 
 
A 75-year-old woman, housewife, non-smoker, 
in good health until the age of 65 when, follow-
ing the appearance of a symptomatology charac-
terized by dry, persistent and resistant cough to 
antibiotic and anti-inflammatory therapy, she 
performed, upon request by a pulmonologist, a 
chest x-ray examination with a negative result. 
Bronchoscopy revealed a thickening of the bron-
chial mucosa at the level of the branches of the 
left lower lobe bronchus. Subsequently, in addi-
tion to the persistence of the cough, she pre-
sented recurrent episodes of productive cough 
(at times with the emission of blood-streaked 
sputum) she manifested fever and dyspnea of 
modest entity. In November 2010 she per-
formed pneumological consultancy at the terri-
torial Pneumo-physiology Service of Lecce, in 
that circumstance the specialist doctor requested 
chest x-ray and CT (Figure 1 and Figure 2). After 
these last examinations which revealed the pres-
ence of a left basal thickening, she was asked to 
perform fibrobronchoscopy. In the latter exam-
ination, the presence of nodular formations at 
the level of the tracheal part was found (Figure 
5), occlusion of the left lower lobe bronchus due 
to the presence of a pseudotumoral mass (Figure 
3), stenosis of the lingula and upper lore bron-
chus proper due to considerable thickening of 
the spur (Figure 4) and stenosis serrata of the 
middle lobar bronchus due to thickening of the 
mucosa (Figure 6). The biopsy examination was 
positive for tracheo-bronchial amyloidosis. 
 
 




Figure 2. Chest CAT. Left lower lobe pulmonary thickening. 
Marked stenosis of the left lower broncho-lobar. 
 
 
Figure 3. Occlusion of the left lower lobe bronchus due to 






Figure 4. Stenosis of the left upper lobe bronchus and of the 
lingula due to marked thickening of the spur. 
 
 
Figure 5. Presence of nodular formations at the level of the 
tracheal wall of amyloid substance. 
 
 
Figure 6. Tight stenosis of the middle broncho-lobar for nota-
ble thickening of the spur between the middle and lower lobe 
bronchus. 
 
 3. Therapy 
 
The YAG laser treatment allows a resection of 
the amyloid pathology with satisfactory results. 
Recently it has been seen that in patients with 
tracheobronchial amyloidosis refractory to YAG 
or stending laser therapy, discrete results can be 
obtained with 20 GY external pulse radiation 
therapy which can be repeated 2/3 times. 
 
4. Conclusions 
This very rare pathology is characterized as we 
have seen from the endoscopic and radiological 
point of view by the presence of multiple nod-
ules, plaques or pseudotumoral masses of easily 
bleeding friable consistency that develop at the 
level of the tracheobronchial wall, causing steno-
sis and sometimes occlusion of some bronchial 
branches. The symptoms in the initial phase can 
be silent or manifest with recurrent episodes of 
bronchial exacerbation. Subsequently, the cough 
becomes persistent and dyspnea and hemoptysis 
appear. The execution of radiological examina-
tions (chest x-ray and CT) and in particular of 
the fibrobronchoscopy with biopsy (better if 
performed in the initial phase) allows to formu-
late the diagnosis and to perform appropriate 
therapy with good results. 
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